|
WO2012052395A1
|
|
Isoxazole derivatives used as oestrogen modulators
|
|
WO2011147764A1
|
|
Thieno (2, 3b) pyrazine compounds as b - raf inhibitors
|
|
TW201130812A
|
|
Amino-heteroaryl derivatives
|
|
WO2011061318A1
|
|
Heterocylic compounds as antagonists of the orexin receptors
|
|
TW201118102A
|
|
Hydroxyasenapine compounds, derivatives thereof and pharmaceutical compositions comprising same
|
|
EP2459594A1
|
|
Fully human antibodies to btla
|
|
US2011020177A1
|
|
Apparatus and method for preserving mucosa
|
|
TW201116531A
|
|
Ring-annulated dihydropyrrolo[2,1-a]isoquinolines
|
|
TW201116515A
|
|
Dihydrobenzoindazoles
|
|
TW201105324A
|
|
2-(1,2-benzisoxazol-3-yl)benzylamine derivatives
|
|
TW201109346A
|
|
Substituted 16,17-annellated steroid compounds for use in women's healthcare
|
|
WO2010128004A1
|
|
Intrauterine system for use in medical treatment
|
|
WO2010115952A1
|
|
Indane derivatives
|
|
AU2010224918A1
|
|
Macrocyclic lactone drug delivery system
|
|
TW201041851A
|
|
Tricyclic heterocyclic derivatives
|
|
TW201043595A
|
|
Tetrahydronaphthalen-2-ol derivatives
|
|
ZA201000956B
|
|
TSH receptor antagonizing tetrahydroquinoline compounds
|
|
US2010184761A1
|
|
6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
|
|
TW201035094A
|
|
6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
|
|
TW201031650A
|
|
1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione
|
